多病共存与流感疫苗接种率的相关性
基于2011至2016年因流感样疾病就诊的成人门诊数据,研究分析多病加权指数(MWI)与流感疫苗接种的关系。3033名参与者中1458人(48%)接种疫苗,MWI与接种呈正线性相关,且MWI模型拟合优于高风险疾病指定。
要点
- 3033名参与者中1458人(48%)接种流感疫苗,接种者中位MWI为1.6,未接种者为0.0(p<0.001)。
- 相比无多病共存者(MWI=0),MWI 1.51-3.00组接种比值比OR为1.58(95%CI 1.26-1.99)。
- MWI的AIC最低,优于高风险疾病指定模型。
核心结论
- 多病共存水平与流感疫苗接种可能性之间存在剂量反应关系,MWI相比高风险疾病指定提供更高精度和更好模型拟合。
研究设计与样本
- 基于门诊的流感疫苗效果研究,纳入2011至2016年间因流感样疾病就诊的≥18岁成人,收集访谈和病历数据,共3033名参与者。
主要发现
- 1458名(48%)参与者接种流感疫苗,接种者中位MWI为1.6,未接种者为0.0(p<0.001)。
- 相比无多病共存者(MWI=0),MWI 0.01-1.50组接种OR为1.17(95%CI 0.92-1.50),MWI 1.51-3.00组OR为1.58(95%CI 1.26-1.99),MWI 3.01-6.00组OR为2.30(95%CI 1.78-2.98),MWI 6.01-45.00组OR为3.14(95%CI 2.41-4.10)。
- 被定义为高风险的参与者接种比值比是非高风险者的1.86倍(OR 1.86,95%CI 1.56-2.21)。
- MWI的AIC最低,优于高风险疾病指定模型。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with chronic conditions have higher rates of severe influenza-related illness and mortality. However, influenza vaccination coverage in high-risk populations continues to be suboptimal. We describe the association between cumulative disease morbidity, measured by a previously validated multimorbidity index, and influenza vaccination among community-dwelling adults. METHODS: We obtained interview and medical record data for participants ≥18 years who sought outpatient care for influenza-like illness between 2011 and 2016 as part of an outpatient-based study of influenza vaccine effectiveness. We defined cumulative disease morbidity by using medical diagnosis codes to calculate a multimorbidity-weighted index (MWI) for each participant. MWI and influenza vaccination status was evaluated by logistic regression. Akaike information criterion was calculated for all models. RESULTS: Overall, 1458 (48%) of participants out of a total of 3033 received influenza vaccination. The median MWI was 0.9 (IQR 0.00-3.5) and was higher among vaccinated participants (median 1.6 versus 0.0; p < 0.001). We found a positive linear association between MWI and vaccination, and vaccination percentages were compared between categories of MWI. Compared to patients with no multimorbidity (MWI = 0), odds of vaccination were 17% higher in the second category (MWI 0.01-1.50; [OR: 1.17, 95% CI: 0.92-1.50]), 58% higher in the third category (MWI 1.51-3.00; [OR: 1.58, 95% CI: 1.26-1.99]), 130% higher in the fourth category (MWI 3.01-6.00; [OR: 2.30, 95% CI: 1.78-2.98]) and 214% higher in the fifth category (MWI 6.01-45.00;[OR: 3.14, 95% CI: 2.41-4.10]). Participants defined as high-risk had 86% greater odds of being vaccinated than non-high-risk individuals (OR: 1.86, 95% CI: 1.56-2.21). The AIC was lowest for MWI compared with high-risk conditions. CONCLUSIONS: Our results suggest a dose response relationship between level of multimorbidity and likelihood of influenza vaccination. Compared with high-risk condition designations, MWI provided improved precision and a better model fit for the measurement of chronic disease and influenza vaccination.
引用
- Harrison SM, Wei MY, Lamerato LE, et al. Multimorbidity is associated with uptake of influenza vaccination. Vaccine. 2018. PMID: 29748031. doi:10.1016/j.vaccine.2018.05.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。